Related Experiment Video
Updated: Sep 12, 2026

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
Published on: February 10, 2026
Acute Kidney Injury and Extreme Rhabdomyolysis due to Carnitine Palmitoyltransferase II Deficiency: A Case Report
1Department of Emergency Medicine, Trabzon University Faculty of Medicine, Kanuni Training and Research Hospital, Trabzon, Turkey.
Background:
Carnitine palmitoyltransferase II (CPT II) deficiency is a rare inherited disorder of long-chain fatty acid oxidation that may present in adulthood with episodic myopathy and rhabdomyolysis. Severe episodes can be life-threatening and may result in acute kidney injury (AKI), particularly when triggered by infection or metabolic stress.
Case Report:
A 47-year-old male presented to the emergency department with influenza-like symptoms and rapidly developed extreme rhabdomyolysis (creatine kinase >126,800 IU/L) and acute kidney injury requiring renal replacement therapy. Dark-colored urine, metabolic acidosis, and multiorgan dysfunction were observed. Continuous renal replacement therapy was initiated in the intensive care unit, resulting in gradual clinical improvement. A detailed family history prompted genetic testing, which revealed a homozygous pathogenic CPT2 mutation (p.Ser113Leu), confirming stress-induced myopathic CPT II deficiency. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: This case emphasizes that inherited metabolic myopathies should be considered in patients presenting with unexplained, extremely elevated creatine kinase levels and acute kidney injury, particularly in the setting of infectious triggers. Early recognition and prompt supportive management in the emergency department are essential to prevent morbidity and mortality.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Nephrotic Syndrome II : Assessment and Medical Management

